DONATE MAINS

SACHA REICHMAN

He is in charge of high throughput drug screening projects using human iPS-derived retinal cells for the treatment of inherited and complex retinal degenerative diseases and his expertise and scientific interests are:

 

  • Drug and target discovery
  • High-throughput screening with human iPSCs;
  • Human iPS cell generation, culture, differentiation and banking;
  • In vitro disease modeling;
  • Genetic engineering and molecular biology.

 

 

Contact: sacha.reichman@inserm.fr

Bio Sketch

 

Back to the team